Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy
Phase 1 Completed
7 enrolled
A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer
Phase 2 Terminated
4 enrolled 9 charts
Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
Phase 1 Completed
15 enrolled
Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML
Phase 2 Withdrawn
Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer
Phase 2 Terminated
35 enrolled
High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors
Phase 2 Terminated
2 enrolled 4 charts
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
Phase 2 Withdrawn
Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
Phase 1/2 Completed
23 enrolled
Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck
Phase 1/2 Completed
48 enrolled
Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer
Phase 2 Unknown
160 enrolled
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
Phase 1 Terminated
13 enrolled
Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia
Phase 2 Terminated
41 enrolled 12 charts
EVALUATION OF AMIFOSTINE FOR MUCOSAL AND HEMOPOETIC PROTECTION AND CARBOPLATIN, TAXOL, RADIOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH HEAD AND NECK CANCER.(GCC 0202)
Phase 2 Completed
21 enrolled 6 charts
Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma
Phase 1 Completed
141 enrolled
High-dose ICE With Amifostine
Phase 2 Completed
24 enrolled
Randomized Amifostine For SCCHN
Phase 2 Completed
58 enrolled
Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer
Phase 1/2 Completed
36 enrolled
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase 1/2 Completed
73 enrolled
Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma
Phase 3 Completed
130 enrolled 6 charts
Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer
Phase 2 Completed
37 enrolled
Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase 2 Completed
34 enrolled
Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect
Phase 1/2 Completed
25 enrolled
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer
Phase 1/2 Completed
11 enrolled
Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer
Phase 1 Withdrawn
Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
Phase 2 Completed
94 enrolled
Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
Phase 2 Completed
24 enrolled
Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation
Phase 2 Completed
20 enrolled
Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer
Phase 2 Completed
80 enrolled
Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment
Phase 2 Terminated
3 enrolled 2 charts
Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer
Phase 1 Completed
24 enrolled
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
Phase 2 Completed
20 enrolled
Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer
Phase 2 Completed
25 enrolled
Amifostine for Head and Neck Irradiation in Lymphoma
Phase 2 Completed
75 enrolled
Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer
Phase 2 Completed
27 enrolled
Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities
Phase NA Completed
20 enrolled
Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck Carcinomas
Phase 3 Completed
296 enrolled